Generated by DeepSeek V3.2| SK Capital Partners | |
|---|---|
| Name | SK Capital Partners |
| Type | Private equity |
| Industry | Investment management |
| Founded | 0 2007 |
| Founders | Jamshid Keynejad, Barry Siadat |
| Hq location | New York City, New York, U.S. |
| Key people | Jamshid Keynejad (Managing Director), Barry Siadat (Managing Director) |
| Products | Leveraged buyout, Growth capital |
| Website | skcapitalpartners.com |
SK Capital Partners. It is a private investment firm focused on the specialty materials, chemicals, and pharmaceuticals sectors. Founded in 2007, the firm employs a collaborative, operationally intensive approach to build market-leading companies. Its strategy involves partnering with management teams to drive innovation, sustainability, and operational excellence within its portfolio.
The firm was established in 2007 by industry veterans Jamshid Keynejad and Barry Siadat, who previously held senior roles at firms like The Sterling Group and American Standard Companies. Its formation coincided with a period of significant activity in the private equity industry, aiming to apply deep sector expertise to complex, chemistry-driven businesses. Early investments targeted niche manufacturers in the chemical industry, leveraging the principals' experience in corporate carve-outs and operational turnarounds. Over the years, it has grown significantly, raising successive funds and expanding its investment activities across North America and Europe. A notable evolution has been its increased focus on sustainability and ESG principles, influencing both investment selection and value creation plans.
The firm utilizes a thematic, research-driven approach, concentrating on the specialty materials, chemicals, and pharmaceuticals sectors where it can apply deep technical and operational knowledge. It typically seeks control-oriented investments in companies with strong intellectual property, such as those involved in advanced polymers, life sciences ingredients, and performance materials. A hallmark of its strategy is active, hands-on partnership with portfolio company management, often involving its in-house team of operating executives to improve manufacturing processes, research and development, and commercial strategies. Investments are often structured as corporate carve-outs, leveraged buyouts, or platforms for add-on acquisitions, with a long-term holding perspective to execute transformational growth.
The firm's portfolio consists of companies that are often leaders in their specific chemical or material niches. Examples have included Ascend Performance Materials, a major producer of nylon resins and chemicals, and SI Group, a global leader in phenolic resins and alkylphenols. In the life sciences sector, it has invested in businesses like Noramco, a supplier of controlled active pharmaceutical ingredients, and Ritedose Corporation, a manufacturer of blow-fill-seal contract services. Other notable companies have involved areas such as electronic chemicals, adhesives, and specialty films, demonstrating a wide application of its sector-focused thesis across various industrial and consumer end markets.
The firm is led by its co-founders and Managing Directors, Jamshid Keynejad and Barry Siadat, who have extensive backgrounds in chemical engineering, operations management, and private equity. The senior team includes other seasoned investment professionals and a dedicated group of operating partners, many of whom are former CEOs or senior executives from major corporations like Dow, DuPont, and Rohm and Haas. This blend of financial and deep industrial expertise is central to its model, allowing for effective collaboration with portfolio company leadership on strategic initiatives, mergers and acquisitions, and operational improvements across the supply chain.
Through its investments, the firm has been recognized for driving significant operational improvements, growth, and sustainability initiatives within the chemical industry. Its work often involves enhancing energy efficiency, developing greener chemistries, and promoting circular economy principles at its portfolio companies. The firm and its executives have been featured in industry publications such as Private Equity International and have participated in forums like the American Chemistry Council. Its focused, long-term approach to building companies in essential but complex industrial sectors has established its reputation as a specialized and influential investor within the global private equity landscape.
Category:Private equity firms of the United States Category:Companies based in New York City Category:Financial services companies established in 2007 Category:Investment management companies